The epidermal growth factor receptor: from development to tumorigenesis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Angelucci, 2006, Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice, Endocr Relat Cancer, 13, 197, 10.1677/erc.1.01100
Arsura, 2005, Nuclear factor-kappaB and liver carcinogenesis, Cancer Lett, 229, 157, 10.1016/j.canlet.2005.07.008
Bachoo, 2002, Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis, Cancer Cell, 1, 269, 10.1016/S1535-6108(02)00046-6
Bailleul, 1990, Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter, Cell, 62, 697, 10.1016/0092-8674(90)90115-U
Ballaro, 2005, Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype, EMBO Rep, 6, 755, 10.1038/sj.embor.7400458
Berasain, 2007, New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system, Liver Int, 27, 174, 10.1111/j.1478-3231.2006.01424.x
Berasain, 2005, Amphiregulin: an early trigger of liver regeneration in mice, Gastroenterology, 128, 424, 10.1053/j.gastro.2004.11.006
Breuhahn, 2006, Dysregulation of growth factor signaling in human hepatocellular carcinoma, Oncogene, 25, 3787, 10.1038/sj.onc.1209556
Britsch, 1998, The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system, Genes Dev, 12, 1825, 10.1101/gad.12.12.1825
Brown, 1998, The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted, Curr Biol, 8, 516, 10.1016/S0960-9822(98)70203-9
Casanova, 2002, A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis, Cancer Res, 62, 3402
Chan, 2000, Expression of epidermal growth factor in transgenic mice causes growth retardation, J Biol Chem, 275, 38693, 10.1074/jbc.M004189200
Chien, 2000, Down-regulation of osteoblastic cell differentiation by epidermal growth factor receptor, Calcif Tissue Int, 67, 141, 10.1007/s00223001128
Chin, 2006, Malignant melanoma: genetics and therapeutics in the genomic era, Genes Dev, 20, 2149, 10.1101/gad.1437206
Choueiri, 2006, The central role of osteoblasts in the metastasis of prostate cancer, Cancer Metastasis Rev, 25, 601, 10.1007/s10555-006-9034-y
Cook, 1997, Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype, J Clin Invest, 100, 2286, 10.1172/JCI119766
David, 2005, Essential role of RSK2 in c-Fos-dependent osteosarcoma development, J Clin Invest, 115, 664, 10.1172/JCI200522877
De Cesare, 1998, Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene, Proc Natl Acad Sci USA, 95, 12202, 10.1073/pnas.95.21.12202
DeClue, 2000, Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models, J Clin Invest, 105, 1233, 10.1172/JCI7610
Di Lorenzo, 2002, Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer, Clin Cancer Res, 8, 3438
Ding, 2003, Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model, Cancer Res, 63, 1106
Dlugosz, 1997, Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras, Cancer Res, 57, 3180
Dobashi, 2007, Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors, Hum Pathol, 38, 914, 10.1016/j.humpath.2006.12.005
Dominey, 1993, Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas, Cell Growth Differ, 4, 1071
Eferl, 2003, Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53, Cell, 112, 181, 10.1016/S0092-8674(03)00042-4
Farazi, 2006, Hepatocellular carcinoma pathogenesis: from genes to environment, Nat Rev Cancer, 6, 674, 10.1038/nrc1934
Ferby, 2006, Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation, Nat Med, 12, 568, 10.1038/nm1401
Fowler, 1995, A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation, Proc Natl Acad Sci USA, 92, 1465, 10.1073/pnas.92.5.1465
Frame, 1998, Epithelial carcinogenesis in the mouse: correlating the genetics and the biology, Philos Trans Roy Soc Lond B Biol Sci, 353, 839, 10.1098/rstb.1998.0248
Friedrichs, 2005, Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer, Mod Pathol, 18, 431, 10.1038/modpathol.3800292
Gassmann, 1995, Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor, Nature, 378, 390, 10.1038/378390a0
Gschwind, 2004, The discovery of receptor tyrosine kinases: targets for cancer therapy, Nat Rev Cancer, 4, 361, 10.1038/nrc1360
Hansen, 1997, Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development, Am J Pathol, 150, 1959
Hart, 2002, A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1, Am J Hum Genet, 70, 943, 10.1086/339689
Herbst, 2002, Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers, Semin Oncol, 29, 27, 10.1053/sonc.2002.31525
Holland, 1998, A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice, Genes Dev, 12, 3675, 10.1101/gad.12.23.3675
Hynes, 2005, ERBB receptors and cancer: the complexity of targeted inhibitors, Nat Rev Cancer, 5, 341, 10.1038/nrc1609
Iwamoto, 2003, Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function, Proc Natl Acad Sci USA, 100, 3221, 10.1073/pnas.0537588100
Jhappan, 1990, TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas, Cell, 61, 1137, 10.1016/0092-8674(90)90076-Q
Ji, 2006, The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies, Cancer Cell, 9, 485, 10.1016/j.ccr.2006.04.022
Jo, 2000, Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells, J Biol Chem, 275, 8806, 10.1074/jbc.275.12.8806
Kiguchi, 1998, Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol, Mol Carcinog, 22, 73, 10.1002/(SICI)1098-2744(199806)22:2<73::AID-MC2>3.0.CO;2-L
Kiguchi, 2000, Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development, Oncogene, 19, 4243, 10.1038/sj.onc.1203778
Kim, 2004, Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice, Cancer Res, 64, 4201, 10.1158/0008-5472.CAN-03-3763
Kleihues, 2002, The WHO classification of tumors of the nervous system, J Neuropathol Exp Neurol, 61, 215, 10.1093/jnen/61.3.215
Kobayashi, 2005, EGFR mutation and resistance of non-small-cell lung cancer to gefitinib, N Engl J Med, 352, 786, 10.1056/NEJMoa044238
Kornblum, 1998, Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor, J Neurosci Res, 53, 697, 10.1002/(SICI)1097-4547(19980915)53:6<697::AID-JNR8>3.0.CO;2-0
Kwak, 2005, Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib, Proc Natl Acad Sci USA, 102, 7665, 10.1073/pnas.0502860102
Lee, 1995, Requirement for neuregulin receptor erbB2 in neural and cardiac development, Nature, 378, 394, 10.1038/378394a0
Lin, 2000, Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice, Proc Natl Acad Sci USA, 97, 1299, 10.1073/pnas.97.3.1299
Ling, 2005, Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis, Cancer Cell, 7, 65, 10.1016/j.ccr.2004.10.016
Luetteke, 1994, The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase, Genes Dev, 8, 399, 10.1101/gad.8.4.399
Luetteke, 1999, Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development, Development, 126, 2739, 10.1242/dev.126.12.2739
Luetteke, 1993, TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice, Cell, 73, 263, 10.1016/0092-8674(93)90228-I
Lynch, 2004, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib, N Engl J Med, 350, 2129, 10.1056/NEJMoa040938
Mann, 1993, Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation, Cell, 73, 249, 10.1016/0092-8674(93)90227-H
Maubec, 2005, Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin, Anticancer Res, 25, 1205
Meyer, 1995, Multiple essential functions of neuregulin in development, Nature, 378, 386, 10.1038/378386a0
Miettinen, 1995, Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor, Nature, 376, 337, 10.1038/376337a0
Miettinen, 1997, Impaired lung branching morphogenesis in the absence of functional EGF receptor, Dev Biol, 186, 224, 10.1006/dbio.1997.8593
Mitchell, 2005, Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration, J Biol Chem, 280, 2562, 10.1074/jbc.M412372200
Murakami, 1993, Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis, Cancer Res, 53, 1719
Murillas, 1995, Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure, Embo J, 14, 5216, 10.1002/j.1460-2075.1995.tb00206.x
Natarajan, 2007, The EGF receptor is required for efficient liver regeneration, PNAS, 101, 17081, 10.1073/pnas.0704126104
Nicholas, 2006, Epidermal growth factor receptor-mediated signal transduction in the development and therapy of gliomas, Clin Cancer Res, 12, 7261, 10.1158/1078-0432.CCR-06-0874
Normanno, 2005, Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis, Endocr Relat Cancer, 12, 471, 10.1677/erc.1.00956
Oda, 1995, Expression of growth factors and their receptors in human osteosarcomas. Immunohistochemical detection of epidermal growth factor, platelet-derived growth factor and their receptors: its correlation with proliferating activities and p53 expression, Gen Diagn Pathol, 141, 97
Ohgaki, 2004, Genetic pathways to glioblastoma: a population-based study, Cancer Res, 64, 6892, 10.1158/0008-5472.CAN-04-1337
Paez, 2004, EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy, Science, 304, 1497, 10.1126/science.1099314
Pao, 2005, Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain, PLoS Med, 2, e73, 10.1371/journal.pmed.0020073
Pao, 2004, EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib, Proc Natl Acad Sci USA, 101, 13306, 10.1073/pnas.0405220101
Pao, 2005, KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib, PLoS Med, 2, e17, 10.1371/journal.pmed.0020017
Perry, 2002, Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms, J Neuropathol Exp Neurol, 61, 702, 10.1093/jnen/61.8.702
Politi, 2006, Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors, Genes Dev, 20, 1496, 10.1101/gad.1417406
Reifenberger, 1996, Epidermal growth factor receptor expression in oligodendroglial tumors, Am J Pathol, 149, 29
Riethmacher, 1997, Severe neuropathies in mice with targeted mutations in the ErbB3 receptor, Nature, 389, 725, 10.1038/39593
Roodman, 2002, Role of the bone marrow microenvironment in multiple myeloma, J Bone Miner Res, 17, 1921, 10.1359/jbmr.2002.17.11.1921
Russell, 1996, Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice, Mol Carcinog, 15, 183, 10.1002/(SICI)1098-2744(199603)15:3<183::AID-MC4>3.0.CO;2-J
Ruther, 1989, c-fos expression induces bone tumors in transgenic mice, Oncogene, 4, 861
Sakata, 1996, Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers, Cell Growth Differ, 7, 1513
Salomon, 1995, Epidermal growth factor-related peptides and their receptors in human malignancies, Crit Rev Oncol Hematol, 19, 183, 10.1016/1040-8428(94)00144-I
Sandgren, 1990, Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast, Cell, 61, 1121, 10.1016/0092-8674(90)90075-P
Sandgren, 1993, Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver, Mol Cell Biol, 13, 320, 10.1128/MCB.13.1.320
Santoni-Rugiu, 1998, Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha, Cancer Res, 58, 123
Schiffer, 2005, Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis, Hepatology, 41, 307, 10.1002/hep.20538
Schlessinger, 2002, Ligand-induced, receptor-mediated dimerization and activation of EGF receptor, Cell, 110, 669, 10.1016/S0092-8674(02)00966-2
Segrelles, 2002, Functional roles of Akt signaling in mouse skin tumorigenesis, Oncogene, 21, 53, 10.1038/sj.onc.1205032
Shachaf, 2004, MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer, Nature, 431, 1112, 10.1038/nature03043
Sharma, 2007, Epidermal growth factor receptor mutations in lung cancer, Nat Rev Cancer, 7, 169, 10.1038/nrc2088
Sharma, 2006, A common signaling cascade may underlie “addiction” to the Src, BCR-ABL, and EGF receptor oncogenes, Cancer Cell, 10, 425, 10.1016/j.ccr.2006.09.014
Sibilia, 2000, The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development, Cell, 102, 211, 10.1016/S0092-8674(00)00026-X
Sibilia, 1998, A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor, Embo J, 17, 719, 10.1093/emboj/17.3.719
Sibilia, 1995, Strain-dependent epithelial defects in mice lacking the EGF receptor, Science, 269, 234, 10.1126/science.7618085
Sibilia, 2003, Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart, Development, 130, 4515, 10.1242/dev.00664
Singh, 2003, Identification of a cancer stem cell in human brain tumors, Cancer Res, 63, 5821
Singh, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128
Sordella, 2004, Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways, Science, 305, 1163, 10.1126/science.1101637
Soulitzis, 2006, Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia, Int J Oncol, 29, 305
Tanaka, 1998, Modulation of osteoclast function by adenovirus vector-induced epidermal growth factor receptor, J Bone Miner Res, 13, 1714, 10.1359/jbmr.1998.13.11.1714
Tarutani, 2003, Inducible activation of Ras and Raf in adult epidermis, Cancer Res, 63, 319
Thorgeirsson, 2002, Molecular pathogenesis of human hepatocellular carcinoma, Nat Genet, 31, 339, 10.1038/ng0802-339
Threadgill, 1995, Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype, Science, 269, 230, 10.1126/science.7618084
Tidcombe, 2003, Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality, Proc Natl Acad Sci USA, 100, 8281, 10.1073/pnas.1436402100
Vassar, 1991, Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation, Genes Dev, 5, 714, 10.1101/gad.5.5.714
Vassar, 1992, Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis, Mol Cell Biol, 12, 4643, 10.1128/MCB.12.10.4643
Vered, 2003, Epidermal growth factor receptor expression in ameloblastoma, Oral Oncol, 39, 138, 10.1016/S1368-8375(02)00034-9
Wagner, 2006, Neuronal survival depends on EGFR signaling in cortical but not midbrain astrocytes, Embo J, 25, 752, 10.1038/sj.emboj.7600988
Wang, 2006, AP-2alpha: a regulator of EGF receptor signaling and proliferation in skin epidermis, J Cell Biol, 172, 409, 10.1083/jcb.200510002
Wang, 2001, Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice, J Cell Biol, 153, 1023, 10.1083/jcb.153.5.1023
Wang, 1994, Epidermal expression of transforming growth factor-alpha in transgenic mice: induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression, Mol Carcinog, 10, 15, 10.1002/mc.2940100104
Wang, 2004, Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment, J Biol Chem, 279, 53848, 10.1074/jbc.M403114200
Watanabe, 1996, Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas, Brain Pathol, 6, 217, 10.1111/j.1750-3639.1996.tb00848.x
Webber, 1994, Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice, Am J Pathol, 145, 398
Weber, 2003, Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice, Cancer Res, 63, 2940
Weiss, 2003, Genetic determinants of malignancy in a mouse model for oligodendroglioma, Cancer Res, 63, 1589
Wen, 2007, Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis, Hum Pathol, 38, 1184, 10.1016/j.humpath.2007.01.002
Woldeyesus, 1999, Peripheral nervous system defects in erbB2 mutants following genetic rescue of heart development, Genes Dev, 13, 2538, 10.1101/gad.13.19.2538
Wong, 2000, Overexpression of epidermal growth factor induced hypospermatogenesis in transgenic mice, J Biol Chem, 275, 18297, 10.1074/jbc.M001965200
Yarden, 2001, Biology of HER2 and its importance in breast cancer, Oncology, 61, 1, 10.1159/000055396
Yarden, 2001, The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities, Eur J Cancer, 37, S3, 10.1016/S0959-8049(01)00230-1
Yarden, 2001, Untangling the ErbB signalling network, Nat Rev Mol Cell Biol, 2, 127, 10.1038/35052073
Yoon, 2000, Epidermal growth factor negatively regulates chondrogenesis of mesenchymal cells by modulating the protein kinase C-alpha, Erk-1, and p38 MAPK signaling pathways, J Biol Chem, 275, 12353, 10.1074/jbc.275.16.12353
Zenz, 2003, c-Jun regulates eyelid closure and skin tumor development through EGFR signaling, Dev Cell, 4, 879, 10.1016/S1534-5807(03)00161-8